Literature DB >> 548213

Clomipramine: plasma levels and clinical effects.

N Reisby, L F Gram, P Bech, F Sihm, O Krautwald, J Elley, J Ortmann, J Christiansen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 548213

Source DB:  PubMed          Journal:  Commun Psychopharmacol        ISSN： 0145-5699


× No keyword cloud information.
  7 in total

1.  Clomipramine metabolism. Model-based analysis of variability factors from drug monitoring data.

Authors:  M Gex-Fabry; A E Balant-Gorgia; L P Balant; G Garrone
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

2.  Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder.

Authors:  Per Bech; Daniel K Kajdasz; Vibeke Porsdal
Journal:  Psychopharmacology (Berl)       Date:  2006-09-08       Impact factor: 4.530

3.  Assessment of symptom change from improvement curves on the Hamilton depression scale in trials with antidepressants.

Authors:  P Bech; P Allerup; N Reisby; L F Gram
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

4.  Clomipramine in obsessive-compulsive ritualisers treated with exposure therapy: relations between dose, plasma levels, outcome and side effects.

Authors:  Y Kasvikis; I M Marks
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  Steady-state plasma levels of clomipramine and its metabolites: impact of the sparteine/debrisoquine oxidation polymorphism. Danish University Antidepressant Group.

Authors:  K K Nielsen; K Brøsen; L F Gram
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

6.  High plasma concentrations of desmethylclomipramine after chronic administration of clomipramine to a poor metabolizer.

Authors:  A E Balant-Gorgia; L Balant; T Zysset
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

7.  Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Danish University Antidepressant Group.

Authors: 
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.